Adam Luo

Adam Luo is a regulatory affairs professional currently working at WuXi Biologics since September 2022, specializing in CMC regulatory affairs strategy, global regulatory compliance, and lifecycle management for biopharmaceutical products. Concurrently, Adam serves as a Venture Analyst at CAV Angels, conducting technical due diligence for startups in various sectors, including pharmaceuticals and biotechnology. Previous consulting experience as a CMC Consultant for DataRevive USA LLC involved regulatory advisory for cross-border biopharma clients. Adam holds a Ph.D. in Chemistry from the University of Virginia, where the focus was on catalysis, and a Master of Science in Chemistry from the University of South Carolina. Key skills include FDA application strategy, drug-device compliance, and digital transformation solutions.